Skip to content
PubMed This is a summary of 87 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 87 referenced papers

Top Authors

Rupesh Agrawal
Singapore National Eye Center
Vishali Gupta
Post Graduate Institute of Medical Education and Research
Ramandeep Singh
Post Graduate Institute of Medical Education and Research
Robin K. Avery
Johns Hopkins University
Genovefa A. Papanicolaou
Memorial Sloan Kettering Cancer Center
Jingyang Wu
Takeda (United States)
Douglas A. Jabs
Johns Hopkins University
Gary N. Holland
Doheny Eye Institute
Yong Tao
Capital Medical University
Francisco M. Marty
Brigham and Women's Hospital

Top Institutions

Ranked by publications Top 10 institutions
03

Post Graduate Institute of Medical Education and Research

Chandigarh, India

8 papers
05
06

Singapore National Eye Center

Singapore, Singapore

7 papers
10

Massachusetts Eye and Ear Infirmary

Boston, United States

7 papers

References

References (87)
  1. 1

    Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion.

    Gupta MP, Coombs P, Prockop SE, et al.

    Ophthalmic surgery, lasers & imaging retina 2015; (46(1)):80-2 doi:10.3928/23258160-20150101-14.

    PMID: 25559515
  2. 2

    Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications.

    Jeon S, Lee WK

    Ocular immunology and inflammation 2015; (23(5)):392-9 doi:10.3109/09273948.2014.985385.

    PMID: 25760914
  3. 3

    Sleepless latency of human cytomegalovirus.

    Poole E, Sinclair J

    Medical microbiology and immunology 2015; (204(3)):421-9 doi:10.1007/s00430-015-0401-6.

    PMID: 25772624
  4. 4

    Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.

    Jabs DA, Ahuja A, Van Natta ML, et al.

    Ophthalmology 2015; (122(7)):1452-63.

    PMID: 25892019
  5. 5

    The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

    Ciáurriz M, Zabalza A, Beloki L, et al.

    Cellular and molecular life sciences : CMLS 2015; (72(21)):4049-62 doi:10.1007/s00018-015-1986-z.

    PMID: 26174234
  6. 6

    Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma.

    Tyagi M, Ambiya V, Mathai A, Narayanan R

    BMJ case reports 2015; (2015()).

    PMID: 26240105
  7. 7

    Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.

    Nishijima T, Yashiro S, Teruya K, et al.

    PloS one 2015; (10(9)):e0136747 doi:10.1371/journal.pone.0136747.

    PMID: 26375282
  8. 8

    Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis.

    Iu LP, Fan MC, Lau JK, et al.

    American journal of ophthalmology 2016; (165()):145-53.

    PMID: 27005706
  9. 9

    Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.

    Kim T, Lee YM, Lee SO, et al.

    The Korean journal of internal medicine 2016; (31(5)):961-70 doi:10.3904/kjim.2015.079.

    PMID: 27055664
  10. 10

    Analysis and Outcomes of Cataract Surgery in Patients with Acquired Immunodeficiency Syndrome.

    Chew GWM, Teoh SCB, Agrawal R

    Ocular immunology and inflammation 2017; (25(4)):535-539 doi:10.3109/09273948.2016.1158281.

    PMID: 27082491
  11. 11

    Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare.

    Leenasirimakul P, Liu Y, Jirawison C, et al.

    The British journal of ophthalmology 2016; (100(8)):1017-21 doi:10.1136/bjophthalmol-2016-308556.

    PMID: 27297217
  12. 12

    Perforation of the bowel due to cytomegalovirus infection in a man with AIDS: surgery is not always necessary!

    Yoganathan KT, Morgan AR, Yoganathan KG

    BMJ case reports 2016; (2016()).

    PMID: 27440845
  13. 13

    Bilateral Cytomegalovirus Retinitis in a Patient with Systemic Lupus Erythematosus.

    Haze M, Kobayashi T, Kakurai K, et al.

    Case reports in ophthalmology 2016; (7(2)):303-8 doi:10.1159/000446391.

    PMID: 27462259
  14. 14

    Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.

    Tabata T, Petitt M, Fang-Hoover J, et al.

    The American journal of pathology 2016; (186(11)):2970-2986 doi:10.1016/j.ajpath.2016.07.016.

    PMID: 27638253
  15. 15

    Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis.

    Liu Y, Chen AS, Kamphaengkham S, et al.

    PloS one 2016; (11(10)):e0165564 doi:10.1371/journal.pone.0165564.

    PMID: 27788232
  16. 16

    Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore.

    Yeo TH, Yeo TK, Wong EP, et al.

    Journal of ophthalmic inflammation and infection 2016; (6(1)):41 doi:10.1186/s12348-016-0110-3.

    PMID: 27822743
  17. 17

    Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.

    Jabs DA, Van Natta ML, Holland GN, et al.

    American journal of ophthalmology 2017; (174()):23-32 doi:10.1016/j.ajo.2016.10.011.

    PMID: 27984023
  18. 18

    COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS.

    Kim DY, Jo J, Joe SG, et al.

    Retina (Philadelphia, Pa.) 2017; (37(2)):376-381 doi:10.1097/IAE.0000000000001144.

    PMID: 28118285
  19. 19

    OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study.

    Invernizzi A, Agarwal A, Ravera V, et al.

    Retina (Philadelphia, Pa.) 2018; (38(1)):108-117 doi:10.1097/IAE.0000000000001503.

    PMID: 28145973
  20. 20

    SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULA-INVOLVING CYTOMEGALOVIRUS RETINITIS.

    Gupta MP, Patel S, Orlin A, et al.

    Retina (Philadelphia, Pa.) 2018; (38(5)):1000-1010 doi:10.1097/IAE.0000000000001644.

    PMID: 28376042
  21. 21

    Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.

    Hassan-Moosa R, Chinappa T, Jeena L, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2017; (107(10)):843-846 doi:10.7196/SAMJ.2017.v107i10.12740.

    PMID: 29022526
  22. 22

    Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients.

    Yashiro S, Nishijima T, Yamamoto Y, et al.

    Japanese journal of ophthalmology 2018; (62(3)):373-389 doi:10.1007/s10384-018-0574-9.

    PMID: 29445945
  23. 23

    Active cytomegalovirus retinitis after the start of antiretroviral therapy.

    Heiden D, Tun N, Smithuis FN, et al.

    The British journal of ophthalmology 2019; (103(2)):157-160 doi:10.1136/bjophthalmol-2018-312406.

    PMID: 30196272
  24. 24

    Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.

    Papanicolaou GA, Silveira FP, Langston AA, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (68(8)):1255-1264 doi:10.1093/cid/ciy706.

    PMID: 30329038
  25. 25

    Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era.

    Singh SR, Dogra M, Kaur S, et al.

    Ocular immunology and inflammation 2020; (28(1)):119-125 doi:10.1080/09273948.2018.1538460.

    PMID: 30395753
  26. 26

    "For your eyes only": ophthalmic complications following lung transplantation.

    Dhal U, Raju S, Singh AD, Mehta AC

    Journal of thoracic disease 2018; (10(11)):6285-6297 doi:10.21037/jtd.2018.09.156.

    PMID: 30622804
  27. 27

    Polymerase chain reaction analysis of aqueous humor specimens in the diagnosis of cytomegalovirus retinitis in AIDS patients.

    Mao F, Sun H, Li D, et al.

    European journal of ophthalmology 2020; (30(4)):738-742 doi:10.1177/1120672119841777.

    PMID: 30968705
  28. 28

    Ultra-Widefield Fundus Autofluorescence in Cytomegalovirus Retinitis.

    Tadepalli S, Bajgai P, Dogra M, et al.

    Ocular immunology and inflammation 2020; (28(3)):446-452 doi:10.1080/09273948.2019.1595671.

    PMID: 31136217
  29. 29

    Infectious uveitis in immunodeficient HIV-negative patients: A retrospective study.

    Svozilkova P, Rihova E, Brichova M, et al.

    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2020; (164(4)):410-416 doi:10.5507/bp.2019.036.

    PMID: 31435074
  30. 30

    Effect of individualized therapy for AIDS patients with cytomegalovirus retinitis in intravitreal ganciclovir injections.

    Xie LY, Chen C, Kong WJ, et al.

    International journal of ophthalmology 2019; (12(8)):1351-1355 doi:10.18240/ijo.2019.08.19.

    PMID: 31456929
  31. 31

    CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION.

    Fan J, Gong D, Truong C, et al.

    Retinal cases & brief reports 2022; (16(2)):199-203 doi:10.1097/ICB.0000000000000928.

    PMID: 31568220
  32. 32

    Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.

    Fu L, Santhanakrishnan K, Al-Aloul M, et al.

    Ocular immunology and inflammation 2020; (28(7)):1152-1158 doi:10.1080/09273948.2019.1645188.

    PMID: 31621449
  33. 33

    Prognostic Factors for Outcome after Vitrectomy for Retinal Detachment Secondary to Cytomegalovirus Retinitis in Patients with AIDS: A Retrospective Single-center Analysis.

    Kong W, Tao Y, Xie L, et al.

    Ocular immunology and inflammation 2021; (29(7-8)):1547-1552 doi:10.1080/09273948.2020.1764591.

    PMID: 32634031
  34. 34

    Clinical features of cytomegalovirus retinitis after solid organ transplantation versus hematopoietic stem cell transplantation.

    Son G, Lee JY, Kim JG, Kim YJ

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2021; (259(3)):585-591 doi:10.1007/s00417-020-04871-w.

    PMID: 32761472
  35. 35

    Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation.

    Kim JY, Hong SY, Park WK, et al.

    PloS one 2020; (15(9)):e0238257 doi:10.1371/journal.pone.0238257.

    PMID: 32877457
  36. 36

    HIV-induced Retinitis.

    Wons J, Kempen J, Garweg JG

    Ocular immunology and inflammation 2020; (28(8)):1259-1268 doi:10.1080/09273948.2020.1808225.

    PMID: 32966142
  37. 37

    Control of Cytokines in Latent Cytomegalovirus Infection.

    Chinta P, Garcia EC, Tajuddin KH, et al.

    Pathogens (Basel, Switzerland) 2020; (9(10)) doi:10.3390/pathogens9100858.

    PMID: 33096622
  38. 38

    Surgical outcomes and prognostic factors following vitrectomy in acquired immune deficiency syndrome patients with cytomegalovirus retinitis-related retinal detachment.

    Sittivarakul W, Prapakornkovit V, Jirarattanasopa P, et al.

    Medicine 2020; (99(43)):e22889 doi:10.1097/MD.0000000000022889.

    PMID: 33120835
  39. 39

    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.

    Mori T, Kikuchi T, Koh M, et al.

    Bone marrow transplantation 2021; (56(6)):1266-1271 doi:10.1038/s41409-020-01176-8.

    PMID: 33311594
  40. 40

    Classification Criteria for Cytomegalovirus Retinitis.

    American journal of ophthalmology 2021; (228()):245-254 doi:10.1016/j.ajo.2021.03.051.

    PMID: 33845015
  41. 41

    Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation.

    Jackson SE, Chen KC, Groves IJ, et al.

    Frontiers in immunology 2021; (12()):657945 doi:10.3389/fimmu.2021.657945.

    PMID: 33912186
  42. 42

    High Blood Cytomegalovirus Load Suggests Cytomegalovirus Retinitis in HIV/AIDS Patients: A Cross-Sectional Study.

    Du KF, Huang XJ, Chen C, et al.

    Ocular immunology and inflammation 2022; (30(7-8)):1559-1563 doi:10.1080/09273948.2021.1905857.

    PMID: 34125650
  43. 43

    Cytomegalovirus Retinitis with Hypopyon Similar to Bacterial Endophthalmitis in a Patient with non-Hodgkin's Lymphoma.

    Seki K, Harimoto K, Takeuchi M

    Ocular immunology and inflammation 2022; (30(7-8)):2017-2018 doi:10.1080/09273948.2021.1944647.

    PMID: 34213982
  44. 44

    Outcomes of 25-gauge pars plana vitrectomy for cytomegalovirus retinitis-related retinal detachment.

    Moharana B, Dogra M, Tigari B, et al.

    Indian journal of ophthalmology 2021; (69(9)):2361-2366 doi:10.4103/ijo.IJO_3539_20.

    PMID: 34427223
  45. 45

    Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.

    Avery RK, Alain S, Alexander BD, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (75(4)):690-701 doi:10.1093/cid/ciab988.

    PMID: 34864943
  46. 46

    Cytomegalovirus-Immune Recovery Retinitis After Initiation of Highly Active Antiretroviral Therapy: A Case Series.

    Qian Y, Wang L, Jiang J, et al.

    Frontiers in medicine 2022; (9()):807013 doi:10.3389/fmed.2022.807013.

    PMID: 35573011
  47. 47

    The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients.

    Mo W, Chen X, Zhang X, et al.

    Frontiers in cellular and infection microbiology 2022; (12()):900154 doi:10.3389/fcimb.2022.900154.

    PMID: 35694535
  48. 48

    Cytomegaloviral Retinitis in a Heart Transplant Patient: Case Report and Review of the Literature.

    Janicka-Maszke Z, Konopa J, Ślizień M, et al.

    Transplantation proceedings 2022; (54(4)):1158-1166 doi:10.1016/j.transproceed.2022.02.068.

    PMID: 35760629
  49. 49

    Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma.

    Tasiopoulou A, Urzua CA, Lightman S

    Eye (London, England) 2023; (37(9)):1895-1903 doi:10.1038/s41433-022-02267-0.

    PMID: 36192634
  50. 50

    Cytomegalovirus retinitis in hospitalized people living with HIV in the late antiretroviral therapy era in São Paulo, Brazil.

    Bogoni G, Lucas Júnior RM, Reis Schneider GA, et al.

    International journal of STD & AIDS 2023; (34(1)):48-53 doi:10.1177/09564624221135294.

    PMID: 36259434
  51. 51

    Risk factors for the long-term prognosis and recurrence of HIV-negative cytomegalovirus retinitis in North China.

    Shi YH, Wang H, Kang H, et al.

    International journal of ophthalmology 2022; (15(10)):1634-1640 doi:10.18240/ijo.2022.10.11.

    PMID: 36262853
  52. 52

    [Relationship between opacity of cytomegalovirus retinitis lesion borders and aqueous viral load among patients after allogeneic hematopoietic stem cell transplantation].

    Lu Y, Hong J, Li HP, et al.

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2022; (58(12)):1033-1038 doi:10.3760/cma.j.cn112142-20220218-00062.

    PMID: 36480884
  53. 53

    Cytomegalovirus retinitis and immune recovery uveitis in a pediatric patient with leukemia.

    Yavuz Saricay L, Baldwin G, Leake K, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2023; (27(1)):52-55 doi:10.1016/j.jaapos.2022.10.004.

    PMID: 36521818
  54. 54

    Predictors for Recurrence of Cytomegalovirus Retinitis in HIV-Negative Patients.

    Tungsattayathitthan U, Singcanvanit R, Choopong P, et al.

    Ocular immunology and inflammation 2024; (32(5)):493-500 doi:10.1080/09273948.2023.2170250.

    PMID: 36749945
  55. 55

    First-line management of necrotizing herpetic retinitis by prioritizing the investigation of immune status and prognostic factors for poor visual outcomes.

    Loubsens E, Adam R, Debard A, et al.

    International ophthalmology 2023; (43(7)):2545-2556 doi:10.1007/s10792-023-02656-8.

    PMID: 36920634
  56. 56

    Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients.

    Razonable RR

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2023; (29(9)):1144-1149 doi:10.1016/j.cmi.2023.03.020.

    PMID: 36963566
  57. 57

    Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation.

    Wang X, Lu Y, Li H, et al.

    Journal of personalized medicine 2023; (13(4)) doi:10.3390/jpm13040639.

    PMID: 37109025
  58. 58

    Proliferative Retinopathy in Non-human Immunodeficiency Virus CMV Retinitis.

    Puri P, Kumar V

    Ocular immunology and inflammation 2024; (32(5)):501-504 doi:10.1080/09273948.2023.2219311.

    PMID: 37290062
  59. 59

    Comparison of two different intravitreal treatment regimens combined with systemic antiviral therapy for cytomegalovirus retinitis in patients with AIDS.

    Liang X, An H, He H, et al.

    AIDS research and therapy 2023; (20(1)):46 doi:10.1186/s12981-023-00543-x.

    PMID: 37452370
  60. 60

    Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation.

    Yuen YS, Holder GE, Lingam G, Shen TYT

    Documenta ophthalmologica. Advances in ophthalmology 2023; (147(2)):139-145 doi:10.1007/s10633-023-09947-6.

    PMID: 37639171
  61. 61

    Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.

    Papanicolaou GA, Avery RK, Cordonnier C, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024; (78(3)):562-572 doi:10.1093/cid/ciad709.

    PMID: 38036487
  62. 62

    Immune recovery uveitis: a focus review.

    Rodrigues Alves N, Barão C, Mota C, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2024; (262(8)):2703-2712 doi:10.1007/s00417-024-06415-y.

    PMID: 38381160
  63. 63

    Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches.

    Hardinger KL, Brennan DC

    The Annals of pharmacotherapy 2024; (58(11)):1122-1133 doi:10.1177/10600280241237534.

    PMID: 38501850
  64. 64

    Ocular involvement in highly treatment-experienced patients with HIV.

    Cobaschi M, Dorobăț CM, Dorobăț VD, et al.

    Romanian journal of ophthalmology 2024; (68(2)):152-157 doi:10.22336/rjo.2024.28.

    PMID: 39006338
  65. 65

    Clinical manifestations and immune markers of non-HIV-related CMV retinitis.

    Passarin O, Hoogewoud F, Manuel O, Guex-Crosier Y

    BMC infectious diseases 2024; (24(1)):787 doi:10.1186/s12879-024-09653-x.

    PMID: 39107686
  66. 66

    Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment.

    Zhang J, Kamoi K, Zong Y, et al.

    Viruses 2024; (16(9)) doi:10.3390/v16091427.

    PMID: 39339903
  67. 67

    Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in taiwan.

    Wu PY, Kang EY, Chen WD, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(2)):393-403 doi:10.1007/s00417-024-06651-2.

    PMID: 39422751
  68. 68

    Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection.

    McCord JL, Han JYS, Staudt RE, et al.

    Science advances 2024; (10(47)):eadn6379 doi:10.1126/sciadv.adn6379.

    PMID: 39565860
  69. 69

    Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell.

    Kim JH, Cho MH, Ban JH, et al.

    Korean journal of ophthalmology : KJO 2025; (39(1)):71-79 doi:10.3341/kjo.2024.0133.

    PMID: 39828283
  70. 70

    Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation.

    Zeng Q, Yao Y, Hou J, Miao H

    Biomedicines 2025; (13(1)) doi:10.3390/biomedicines13010242.

    PMID: 39857825
  71. 71

    Navigating Cytomegalovirus Retinitis in a Patient With Myelodysplastic Syndromes Transitioning to Acute Myeloid Leukemia Post Transplant: A Case Study.

    Benyahia SA, Kahlon S, Paul S, et al.

    Cureus 2025; (17(2)):e78491 doi:10.7759/cureus.78491.

    PMID: 40051959
  72. 72

    Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma.

    Kikuchi T, Watanabe M, Tsukada N, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2025; (27(4)):e70040 doi:10.1111/tid.70040.

    PMID: 40257295
  73. 73

    Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Immune Recovery Uveitis.

    Koc H, Bayram U

    Ocular immunology and inflammation 2025; (33(7)):1495-1500 doi:10.1080/09273948.2025.2496977.

    PMID: 40265289
  74. 74

    Comparison of Clinical Characteristics Among Herpetic Retinitis: Acute Retinal Necrosis and Cytomegalovirus Retinitis.

    Hirai H, Kuraoka D, Ueda T, Kase S

    Ocular immunology and inflammation 2025; (33(8)):1679-1687 doi:10.1080/09273948.2025.2522955.

    PMID: 40556108
  75. 75

    Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients.

    Lind KT, DeSmith K, Marks B, et al.

    Pediatric blood & cancer 2025; (72(10)):e31910 doi:10.1002/pbc.31910.

    PMID: 40682285
  76. 76

    International consensuses and guidelines on diagnosing and managing cytomegalovirus (CMV) retinitis by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Professors of Ophthalmology (AAPPO) and the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII).

    Hwang DK, Ng DSC, Qian Z, et al.

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025; (14(5)):100248 doi:10.1016/j.apjo.2025.100248.

    PMID: 41038280
  77. 77

    Cytomegalovirus Retinitis Complicated With Rhegmatogenous Retinal Detachment in a Non-HIV Patient With Pure Red Cell Aplasia.

    Tan CM, Noram MS

    Cureus 2025; (17(9)):e92998 doi:10.7759/cureus.92998.

    PMID: 41141209
  78. 78

    A case series: cytomegalovirus retinitis following autologous hematopoietic cell transplantation: a call for early detection and aggressive management.

    Zhou Y, Liu M, Zhang J, et al.

    Frontiers in medicine 2025; (12()):1693928 doi:10.3389/fmed.2025.1693928.

    PMID: 41179870
  79. 79

    Maribavir for cytomegalovirus retinitis: A case series and review of the literature.

    Shughoury A, Emami S, Kaisari E, et al.

    AJO international 2026; (3(2)) doi:10.1016/j.ajoint.2026.100247.

    PMID: 41938663
  80. 80

    Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis.

    Amiri I, Shah P, Soleimani M, Zhang AY

    The Journal of international medical research 2026; (54(4)):3000605261436565 doi:10.1177/03000605261436565.

    PMID: 41986961
  81. 81

    Risk Factors for Immune Recovery Uveitis in Patients with Cytomegalovirus Retinitis After Hematopoietic Stem Cell Transplantation.

    Kim JY, Park YG, Lee DG, Park YH

    Ocular immunology and inflammation 2026; (34(4)):723-730 doi:10.1080/09273948.2026.2620452.

    PMID: 41996150
  82. 82

    Ultra-widefield retinal imaging for early detection of asymptomatic cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation: a prospective pilot feasibility study.

    Moll-Udina A, Pedraza A, Miguel-Escuder L, et al.

    Journal of ophthalmic inflammation and infection 2026; (16(1)).

    PMID: 42047905
  83. 83

    Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis: Multimodal Imaging in Uveitis (MUV) Task Force - Report 15.

    Leal I, Agarwal A, Berkenstock M, et al.

    Ophthalmology. Retina 2026; doi:10.1016/j.oret.2026.05.004.

    PMID: 42119730
  84. 84

    Risk factors for ocular complications in HIV/AIDS patients: a retrospective analysis of ophthalmology consultations in a tertiary hospital in Central China.

    Zhang R, Zheng T, Chen X, et al.

    BMC ophthalmology 2026; (26(1)).

    PMID: 42174527
  85. 85

    Beyond CD4: Posterior segment findings and virologic-immunologic predictors in highly active antiretroviral therapy-naïve HIV patients.

    Hayat SC, Yilmaz YC, Gunduz A, et al.

    Indian journal of ophthalmology 2026; (74(6)):901-907 doi:10.4103/IJO.IJO_1957_25.

    PMID: 42200741
  86. 86

    Herpesvirus Retinitis by Immune Status: Clinical Phenotypes and Predictors of Retinal Detachment and Severe Visual Impairment.

    Zou Y, Yang M, Zhang J, et al.

    Ophthalmology. Retina 2026; doi:10.1016/j.oret.2026.06.002.

    PMID: 42252088
  87. 87

    Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation.

    Kaynar L, Ali IA, Alrais M, et al.

    Journal of clinical medicine 2026; (15(16)) doi:10.3390/jcm15166365.

    PMID: 42652768